Additionally, some research suggests that PCSK9 inhibitors may reduce cancer cell proliferation by altering cholesterol availability, which is essential for membrane synthesis and cellular signaling in rapidly dividing tumor cells [105]. Here, PCSK9 is linked to cancer.